You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune biomarker

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Biomarker Study for Salivary Gland Carcinoma

Not yet recruiting
  • Salivary Gland Tumor
  • Benign Salivary Gland Tumor
  • Sampling
  • Erlangen, Bavaria, Germany
  • +1 more
Sep 21, 2023

Immune Biomarker Study for Head and Neck Cancer

Recruiting
  • Head and Neck Cancer
  • +4 more
  • Sampling
  • Erlangen, Bavaria, Germany
  • +2 more
Jan 23, 2023

Immune Effector Cell-Associated Neurotoxicity Syndrome

Not yet recruiting
  • Immune Effector Cell Associated Neurotoxicity Syndrome
    • (no location specified)
    Dec 1, 2022

    Intestinal Biomarker Analysis After ECP for ICI Colitis

    Recruiting
    • Colitis
    • Immune Checkpoint Inhibitor-Related Colitis
    • Intestinal tissue analysis
    • Freiburg, Baden Württemberg, Germany
      Freiburg University Medical Center
    Oct 5, 2023

    Repeated Embryo Implantation Failure, Recurrent Miscarriage, Immune System Trial in Amiens (blood sample)

    Recruiting
    • Repeated Embryo Implantation Failure
    • +2 more
    • blood sample
    • Amiens, Picardie, France
      Centre Hospitalier Universitaire d'Amiens
    Dec 5, 2022

    Carcinoma, Squamous Cell Trial in United States (VTX-2337, Nivolumab)

    Completed
    • Carcinoma, Squamous Cell
    • Birmingham, Alabama
    • +6 more
    Feb 23, 2022

    Colorectal Cancer, Anesthesia, Cancer Metastatic Trial (Lidocaine IV, Dexmedetomidine IV, intrathecal morphine)

    Not yet recruiting
    • Colorectal Cancer
    • +3 more
    • Lidocaine IV
    • +2 more
    • (no location specified)
    Feb 14, 2023

    Immune Deficiency Trial in Charlottesville (Salmonella typhi polysaccharide vaccine)

    Recruiting
    • Immune Deficiency
    • Salmonella typhi polysaccharide vaccine
    • Charlottesville, Virginia
      University of Virginia Health System
    May 16, 2022

    High PD-L1 Expressing NSCLC Patients Treated With PD-1/PD-L1

    Suspended
    • NSCLC Stage IV
    • NSCLC, Stage IIIC
    • Primary Immune Response (PIR) test by Biodesix, Inc.
    • San Carlos, California
    • +1 more
    Jan 26, 2023

    Response in Patients Treated by Immunotherapy for Advanced

    Not yet recruiting
    • Hepatocellular Carcinoma
    • patients with hepatocellular carcinoma
    • (no location specified)
    Jan 28, 2022

    Patients With Cancer Undergoing Radiation Therapy

    Terminated
    • Malignant Neoplasm
    • cytology specimen collection procedure
    • laboratory biomarker analysis
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center
    Aug 15, 2022

    Microbiome on Immune Checkpoint Inhibitor Response in Melanoma

    Active, not recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • Pathologic Stage IV Cutaneous Melanoma AJCC v8
    • Biospecimen Collection
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    May 31, 2022

    Volatile Organic Compounds asBiomarker in Immune-mediated

    Recruiting
    • Pulmonary Arterial Hypertension
    • +2 more
      • Maastricht, Netherlands
        Maastricht University Medical Center
      Sep 7, 2021

      Hodgkin Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage II Adult Hodgkin Lymphoma Trial in Rochester (drug, genetic, other)

      Withdrawn
      • Hodgkin Lymphoma
      • +4 more
      • Rochester, Minnesota
        Mayo Clinic
      Nov 28, 2022

      Multiple Sclerosis Trial in Los Angeles (Blood draw for future biomarker analysis)

      Completed
      Has Results
      • Multiple Sclerosis
      • Blood draw for future biomarker analysis
      • Los Angeles, California
        Investigational Site Number 8400001
      Mar 15, 2022

      Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8 Trial in San Francisco (Pembrolizumab,

      Recruiting
      • Anatomic Stage IV Breast Cancer AJCC v8
      • Prognostic Stage IV Breast Cancer AJCC v8
      • Pembrolizumab
      • +2 more
      • San Francisco, California
        University of California, San Francisco
      Jan 5, 2023

      Peripheral Blood for Nivolumab Therapy in NSCLC Patients

      Completed
      • Non -Small Cell Lung Cancer
      • nivolumab
      • Seoul, Korea, Korea, Republic of
        Department of Oncology, Yonsei University College of Medicine
      Oct 14, 2020

      Prostate Cancer, Recurrent Prostate Carcinoma, Stage IV Prostate Adenocarcinoma Trial in Baltimore (Ipilimumab, Nivolumab,

      Completed
      Has Results
      • Prostate Cancer
      • +2 more
      • Ipilimumab
      • +2 more
      • Baltimore, Maryland
        Johns Hopkins University/Sidney Kimmel Cancer Center
      Jan 6, 2022

      Checkpoint Inhibitor Response

      Active, not recruiting
      • NSCLC
      • +4 more
      • Breathprint analysis and patient-reported outcomes
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Feb 24, 2022

      Nasopharyngeal Carcinoma Trial in Guangzhou (GP+DDP, Palbociclib, Intensity-modulated radiotherapy)

      Not yet recruiting
      • Nasopharyngeal Carcinoma
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Sep 2, 2021

      Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and

      Recruiting
      • HNSCC
      • +6 more
      • Conventional Therapy acc. to prevailing clincal approved schemes
      • Erlangen, Bavaria, Germany
        Department of Radiation Oncology, Universitätsklinikum Erlangen
      May 18, 2021

      Qualitative, Qualitative, and Functional Studies Over First Year

      Completed
      • Astrocytoma
      • +2 more
      • Hepatitis A Vaccine
      • +3 more
      • Winston-Salem, North Carolina
        Comprehensive Cancer Center of Wake Forest University
      Oct 28, 2021

      Glioma, Malignant Trial in United States (biological, drug, radiation, other)

      Active, not recruiting
      • Glioma, Malignant
      • AdV-tk
      • +5 more
      • Los Angeles, California
      • +7 more
      Jan 30, 2023

      Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle

      Recruiting
      • Metastatic Leiomyosarcoma
      • +17 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Oct 13, 2022

      Hodgkin Disease Trial in Houston (ABVE-PC, DECA)

      Active, not recruiting
      • Hodgkin Disease
      • Houston, Texas
        Texas Children's Hospital
      Jan 19, 2022